Skip to content

APOTHEEK VLOEMANS

Active
Private limited companyfounded 1989active for 37 yearsBinnenhof 18, 2930 Brasschaat, BelgiumKBO/BCE: BE 0438.382.590
Summary

APOTHEEK VLOEMANS has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €519,817 and a net result of €266,189. Equity has been growing by about 5.8% per year since 2018. Its solvency ranks better than 67% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 05-09-1989 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment units
2.045.446.423 2930 Brasschaat, since 06-11-1989
2.045.446.522 2270 Herenthout, since 06-11-1989
Financial year end
31 December
Peppol
Reachable since 27-03-2026

Board and ownership

Board
  • Heps IngridDirector · since 01-01-2018
  • Vloemans Jean-ClaudeDirector · since 18-11-2020

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€761,638
▲ 6.4%
Turnover
≈ €2.8m
estimated
Profit
€266,189
▲ 23.5%
Equity
€519,817
=
Total assets
€982,280
▲ 3.9%
Employees on 31-12-2025
5
=
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.87, cash €384,409Founded in 1989Equity €519,817 (52.9% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 71% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 78-2
equity 52.9% of total assets
Liquidity 76-3
short-term debt 46.5% · cash 39.1%
Profitability 100+3
return on assets 27.1%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025lowest value 05-2025: 0.1%● unchanged vs 04-2025lowest value 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025highest value 08-2025: 0.1%● unchanged vs 07-2025highest value 09-2025: 0.1%● unchanged vs 08-2025highest value 10-2025: 0.1%● unchanged vs 09-2025highest value 11-2025: 0.1%● unchanged vs 10-2025highest value 12-2025: 0.1%● unchanged vs 11-2025highest value 01-2026: 0.1%● unchanged vs 12-2025highest value 02-2026: 0.1%● unchanged vs 01-2026highest value 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.87 (1.96 in 2024), above the usual 1.5. Short-term debt is 46.5% and cash 39.1% of total assets. 47.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 67% of them on solvency, 81% on liquidity, 96% on profitability and 39% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.87, cash €384,409
NBB · annual accounts
lowers risk · Founded in 1989
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Equity €519,817 (52.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
38 days early
2024
59 days early
2023
54 days early
2022
54 days early
2021
11 days early
2020
30 days early
2019
8 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 36 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 91% of companies in retail tradesector median €27,601 · 12,764 companies €266,189 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €266,189 8 years View

Recent changes

  1. · Gazette deed Amendment of the articles · Legal-form change · Miscellaneous
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as APOTHEEK VLOEMANS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €956,000 and €1.2m, founded between 1979 and 1999.

CompanyTotal assetsGross margin
APOTHEEK VLOEMANS Brasschaat€1.0m€0.8m
APOTHEEK SNEYERS - SOL Oud-Turnhout€1.2m€0.7m
APOTHEEK TILIA Edegem€1.0m€0.7m
APOTEEK ROOYACKERS Beveren-Kruibeke-Zwijndrecht€1.1m€0.7m
APOTHEEK TENNSTEDT-LEVIE Overijse€1.0m€0.7m
SMEETS TOM Lint€1.0m€0.6m
MEDIGREX Wuustwezel€1.2m€0.6m
Full comparison

Key facts about APOTHEEK VLOEMANS

What is the company number of APOTHEEK VLOEMANS?
The company number of APOTHEEK VLOEMANS is 0438.382.590. The VAT number is the same number with BE in front: BE 0438.382.590.
Where is APOTHEEK VLOEMANS based?
The registered office is at Binnenhof 18, 2930 Brasschaat.Company details
What does APOTHEEK VLOEMANS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VLOEMANS?
The legal form of APOTHEEK VLOEMANS is Private limited company (BV).
When was APOTHEEK VLOEMANS founded?
APOTHEEK VLOEMANS was founded on 05-09-1989.
Is APOTHEEK VLOEMANS still active?
Yes, APOTHEEK VLOEMANS is an active enterprise in the KBO register.
How many employees does APOTHEEK VLOEMANS have?
APOTHEEK VLOEMANS had an average of 4.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK VLOEMANS?
The turnover in financial year 2025 is ≈ €2.8m. This figure is estimated from the gross margin of €761,638 and 47 comparable companies (NACE 477). It probably lies between €2.2m and €4.6m.
Is APOTHEEK VLOEMANS profitable?
In financial year 2025, APOTHEEK VLOEMANS made a profit of €266,189.
Where can I find the annual accounts of APOTHEEK VLOEMANS?
APOTHEEK VLOEMANS filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VLOEMANS due?
APOTHEEK VLOEMANS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.